Post COVID-19 Impact on Cancer Stem Cell Market and its Market Forecast to 2026 – Jewish Life News

Post COVID-19 Impact on Cancer Stem Cell Market

With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues.

Research Dive group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive study by our qualified team of experts.

Our study helps to acquire the following:

Well help you fight this crisis through our business intelligence solutions.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/32

Pre COVID-19 Analysis on Cancer Stem Cell Market

According to a study by the World Health Organization (WHO), cancer is the cause for every one death out of six occurrences. Growing cases of cancers such as breast cancer, lung cancer and others due to poor diet patterns, air pollution, sexually transmitted infections, alcohol consumption. Other types of cancer are liver cancer, pancreas cancer, brain cancer, bladder cancer, colon, and blood cancer. The most common cures for cancer are chemotherapy, radiation, and surgeries. These procedures have an adverse effect on the human body. High doses of radiation and chemotherapy destroy the blood-forming stem cells. Stem cells are the soft tissues of the bone that grow inside the bone marrow. Stem cell transplants restore the blood-forming stem cells. These stem cells grow into platelets, RBCs, and WBCs that are required by the body to fight illness and provide oxygen. Usually, these transplants are done within the family to find the closest match.

According to a study,Cancer Stem Cells Marketby Research Dive, the global market will surpass $1,722.7 million by 2026. Rising number of cancer patients, coupled with the latest advancements in cancer stem cells will upsurge the global market by the year 2026.

Regional Investment Opportunities:

North America cancer stem cell market is generated revenue of $365.64 million by end of 2018 and is anticipated to rise at 10% CAGR during the analyzed period. Asia-Pacific market registered a growth rate of 11.2% during the forecast period. This market will surpass $367.68 million by 2026, growing from $157.26 million in 2018. China, India, and Japan are the key contributors to the growth of regional market.

Check out How Stem-cell based cancer segment is will generate revenue of $896.9 Mn by the year of 2026. Click here to know more in details @ https://www.researchdive.com/purchase-enquiry/32

Stem Cells for Cancer

Cancer stem cells or CSCs are a subpopulation of cells that has the driving force of carcinogenesis. Characteristics of cancer stem cells are proliferation, and differentiation capabilities and distinctive self-renewal. These characteristics play a vital role in many stages of cancer such as cancer initiation, drug resistance, progression, maintenance, and metastasis or relapse. CSCs have traits that are linked with normal stem cells and are found within hematological cancers or tumors.

Check out How Cancer stem cells market for breast cancer is projected to hold a dominant share, owing to the genetic influences & alcohol use @ https://www.researchdive.com/download-sample/32

Stem Cell-based therapy

According to the World Health Organization (WHO), the most common cause of deaths in women diagnosed with cancer is breast cancer.Global cancer stem cells marketis projected to reach up to $896.9 million by the end of 2026 as the stem cell-based cancer therapy and targeted cancerous stem cell therapy are advancing in the medical field. Cell-based therapy is split into allogenic Stem Cell therapy and autologous Stem Cell therapy. Allogenic Hematopoietic Stem Cell Transplantation is more beneficial than the autologous Hematopoietic Stem Cell Transplantation for Breast cancer based on different aspects such as cancer-free graft & immune-mediated Graft vs Tumor effect mediated by the donors immune cell.

Successful engraftment rates together with lesser transplant-related mortality and the presence of Graft vs Tumor effect made allogeneic Hematopoietic Stem Cell Transplantation with Reduced Intensity conditioning is the better choice option for the treatment of multiple solid tumors. Due to aforesaid aspects, it is anticipated that allogenic cell therapy will be the rising point for the cancer stem cell market. The global market for stem cell-based cancer therapy is estimated to grow at 9.3% CAGR in 2026 from $440.3 million in 2018.

Advancements in Cancer Stem Cell Transplantation

The prime reason for such huge growth is majorly owed to the rising developments in stem cell therapy of the Asia-Pacific and Europe region. Physicians in Canada are endorsing and promotion of stem cell interventions, which are ethical, legal, and regulatory. U.S. and Canada are leading the cancer stem cell market in the North America region. The North America market is expected to grow over the forecast period and is further projected to generate revenue of $783.8 million by 2026 from its market value of $365.6 million in 2018. While the Asia-Pacific Cancer Stem Cells Market is anticipated to rise to $367.7 Million till 2026 and the Europe Cancer Stem Cells Market is anticipated to generate revenue of $419.5 Million till 2026. Amongst these regions, the Asia-Pacific region is anticipated to be the fastest-growing region for cancer stem cells market. Governing bodies of India, Japan, and other countries are promoting Stem cell transplant by constructing new infrastructure and enlisting new strategies for the launch of centers of stem cells.

The major players in the global cancer stem cell market are introducing several strategies to reinforce their presence in the market

Get Access to Full Report (TOC, Figures, Chart, etc.) @ https://www.researchdive.com/32/cancer-stem-cells-market

Segmentation Growth Definition of Cancer Stem Cells Market:

Breast cancer market will surpass $295.0 million in the year 2026, and is anticipated to rise at 10.4% CAGR during the estimate period. The cancer stem cells market for bladder is anticipated to increase at 11.2% CAGR, and will surpass $275.8 million by 2026, rising from $117.9 million in 2018. Global market for stem cell based cancer therapy was $440.3 million by end of 2018 and is anticipated to grow at 9.3% CAGR. This is majorly due to the rising advancements in stem cell therapy of Asia-Pacific and Europe region.

About Us: Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact us: Mr. Abhishek Paliwal Research Dive 30 Wall St. 8th Floor, New York NY 10005 (P) + 91 (788) 802-9103 (India) +1 (917) 444-1262 (US) Toll Free: +1-888-961-4454 E-mail: [emailprotected] LinkedIn:https://www.linkedin.com/company/research-dive/ Twitter:https://twitter.com/ResearchDive Facebook:https://www.facebook.com/Research-Dive-1385542314927521 Blog:https://www.researchdive.com/blog Follow us:https://marketinsightinformation.blogspot.com/

See original here:
Post COVID-19 Impact on Cancer Stem Cell Market and its Market Forecast to 2026 - Jewish Life News

COVID-19 Impact on Platelet Rich Plasma and Stem Cell Alopecia Treatment Identify Which Types of Companies Could Potentially Benefit or Loose out…

Complete study of the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Platelet Rich Plasma and Stem Cell Alopecia Treatment industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Platelet Rich Plasma and Stem Cell Alopecia Treatment production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

Key companies operating in the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market include _Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, RepliCel Life Sciences, Histogen, Glofinn Oy., Platelet Rich Plasma and Stem Cell Alopecia Treatment

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/index/detail/1658983/global-platelet-rich-plasma-and-stem-cell-alopecia-treatment-market

Segmental Analysis

The report has classified the global Platelet Rich Plasma and Stem Cell Alopecia Treatment industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Platelet Rich Plasma and Stem Cell Alopecia Treatment manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Platelet Rich Plasma and Stem Cell Alopecia Treatment industry.

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Segment By Type:

, Androgenic Alopecia, Congenital Alopecia, Cicatricial Or Scarring Alopecia

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Segment By Application:

, Hospital, Dermatology Clinic, Other

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Platelet Rich Plasma and Stem Cell Alopecia Treatment industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Platelet Rich Plasma and Stem Cell Alopecia Treatment market include _Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, RepliCel Life Sciences, Histogen, Glofinn Oy., Platelet Rich Plasma and Stem Cell Alopecia Treatment

Key questions answered in the report:

Enquire Customization in The Report: https://www.qyresearch.com/customize-request/form/1658983/global-platelet-rich-plasma-and-stem-cell-alopecia-treatment-market

TOC

1 Study Coverage 1.1 Platelet Rich Plasma and Stem Cell Alopecia Treatment Product Introduction 1.2 Market Segments 1.3 Key Platelet Rich Plasma and Stem Cell Alopecia Treatment Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Growth Rate by Type 1.4.2 Androgenic Alopecia 1.4.3 Congenital Alopecia 1.4.4 Cicatricial Or Scarring Alopecia 1.5 Market by Application 1.5.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Growth Rate by Application 1.5.2 Hospital 1.5.3 Dermatology Clinic 1.5.4 Other 1.6 Coronavirus Disease 2019 (Covid-19): Platelet Rich Plasma and Stem Cell Alopecia Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Platelet Rich Plasma and Stem Cell Alopecia Treatment Industry 1.6.1.1 Platelet Rich Plasma and Stem Cell Alopecia Treatment Business Impact Assessment Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Platelet Rich Plasma and Stem Cell Alopecia Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Platelet Rich Plasma and Stem Cell Alopecia Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Estimates and Forecasts 2.1.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue 2015-2026 2.1.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales 2015-2026 2.2 Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size by Region: 2020 Versus 2026 2.2.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Competitor Landscape by Players 3.1 Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Manufacturers 3.1.1 Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Manufacturers (2015-2020) 3.1.2 Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Market Share by Manufacturers (2015-2020) 3.2 Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Manufacturers 3.2.1 Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Manufacturers (2015-2020) 3.2.2 Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue in 2019 3.2.5 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Platelet Rich Plasma and Stem Cell Alopecia Treatment Price by Manufacturers 3.4 Platelet Rich Plasma and Stem Cell Alopecia Treatment Manufacturing Base Distribution, Product Types 3.4.1 Platelet Rich Plasma and Stem Cell Alopecia Treatment Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Platelet Rich Plasma and Stem Cell Alopecia Treatment Product Type 3.4.3 Date of International Manufacturers Enter into Platelet Rich Plasma and Stem Cell Alopecia Treatment Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size by Type (2015-2020) 4.1.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Type (2015-2020) 4.1.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Type (2015-2020) 4.1.3 Platelet Rich Plasma and Stem Cell Alopecia Treatment Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast by Type (2021-2026) 4.2.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast by Type (2021-2026) 4.2.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast by Type (2021-2026) 4.2.3 Platelet Rich Plasma and Stem Cell Alopecia Treatment Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size by Application (2015-2020) 5.1.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Application (2015-2020) 5.1.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Application (2015-2020) 5.1.3 Platelet Rich Plasma and Stem Cell Alopecia Treatment Price by Application (2015-2020) 5.2 Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast by Application (2021-2026) 5.2.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast by Application (2021-2026) 5.2.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast by Application (2021-2026) 5.2.3 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Price Forecast by Application (2021-2026) 6 North America 6.1 North America Platelet Rich Plasma and Stem Cell Alopecia Treatment by Country 6.1.1 North America Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Country 6.1.2 North America Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Type 6.3 North America Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Application 7 Europe 7.1 Europe Platelet Rich Plasma and Stem Cell Alopecia Treatment by Country 7.1.1 Europe Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Country 7.1.2 Europe Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Type 7.3 Europe Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Platelet Rich Plasma and Stem Cell Alopecia Treatment by Region 8.1.1 Asia Pacific Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Region 8.1.2 Asia Pacific Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Type 8.3 Asia Pacific Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Application 9 Latin America 9.1 Latin America Platelet Rich Plasma and Stem Cell Alopecia Treatment by Country 9.1.1 Latin America Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Country 9.1.2 Latin America Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Type 9.3 Central & South America Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Platelet Rich Plasma and Stem Cell Alopecia Treatment by Country 10.1.1 Middle East and Africa Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales by Country 10.1.2 Middle East and Africa Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Type 10.3 Middle East and Africa Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Facts & Figures by Application 11 Company Profiles 11.1 Kerastem 11.1.1 Kerastem Corporation Information 11.1.2 Kerastem Description, Business Overview and Total Revenue 11.1.3 Kerastem Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Kerastem Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.1.5 Kerastem Recent Development 11.2 Eclipse 11.2.1 Eclipse Corporation Information 11.2.2 Eclipse Description, Business Overview and Total Revenue 11.2.3 Eclipse Sales, Revenue and Gross Margin (2015-2020) 11.2.4 Eclipse Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.2.5 Eclipse Recent Development 11.3 Regen Lab SA 11.3.1 Regen Lab SA Corporation Information 11.3.2 Regen Lab SA Description, Business Overview and Total Revenue 11.3.3 Regen Lab SA Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Regen Lab SA Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.3.5 Regen Lab SA Recent Development 11.4 Stemcell Technologies 11.4.1 Stemcell Technologies Corporation Information 11.4.2 Stemcell Technologies Description, Business Overview and Total Revenue 11.4.3 Stemcell Technologies Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Stemcell Technologies Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.4.5 Stemcell Technologies Recent Development 11.5 RepliCel Life Sciences 11.5.1 RepliCel Life Sciences Corporation Information 11.5.2 RepliCel Life Sciences Description, Business Overview and Total Revenue 11.5.3 RepliCel Life Sciences Sales, Revenue and Gross Margin (2015-2020) 11.5.4 RepliCel Life Sciences Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.5.5 RepliCel Life Sciences Recent Development 11.6 Histogen 11.6.1 Histogen Corporation Information 11.6.2 Histogen Description, Business Overview and Total Revenue 11.6.3 Histogen Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Histogen Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.6.5 Histogen Recent Development 11.7 Glofinn Oy. 11.7.1 Glofinn Oy. Corporation Information 11.7.2 Glofinn Oy. Description, Business Overview and Total Revenue 11.7.3 Glofinn Oy. Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Glofinn Oy. Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.7.5 Glofinn Oy. Recent Development 11.1 Kerastem 11.1.1 Kerastem Corporation Information 11.1.2 Kerastem Description, Business Overview and Total Revenue 11.1.3 Kerastem Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Kerastem Platelet Rich Plasma and Stem Cell Alopecia Treatment Products Offered 11.1.5 Kerastem Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Estimates and Projections by Region 12.1.1 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast by Regions 2021-2026 12.1.2 Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast by Regions 2021-2026 12.2 North America Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast (2021-2026) 12.2.1 North America: Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast (2021-2026) 12.2.2 North America: Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast (2021-2026) 12.2.3 North America: Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast by Country (2021-2026) 12.3 Europe Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast (2021-2026) 12.3.1 Europe: Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast (2021-2026) 12.3.2 Europe: Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast (2021-2026) 12.3.3 Europe: Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast by Region (2021-2026) 12.5 Latin America Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast (2021-2026) 12.5.1 Latin America: Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast (2021-2026) 12.5.2 Latin America: Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast (2021-2026) 12.5.3 Latin America: Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Platelet Rich Plasma and Stem Cell Alopecia Treatment Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Platelet Rich Plasma and Stem Cell Alopecia Treatment Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porters Five Forces Analysis 13.5 Primary Interviews with Key Platelet Rich Plasma and Stem Cell Alopecia Treatment Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Platelet Rich Plasma and Stem Cell Alopecia Treatment Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

View post:
COVID-19 Impact on Platelet Rich Plasma and Stem Cell Alopecia Treatment Identify Which Types of Companies Could Potentially Benefit or Loose out...

Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice – The Scientist

Turning off just one factor in the brains astrocyte cells is sufficient to convert them into neurons in live mice, according to a paper published in Nature today (June 24) and one this spring by another research team in Cell. By flipping this cellular identity switch, researchers have, to some extent, been able to reverse the neuron loss and motor deficits caused by a Parkinsons-like illness. Not everyone is entirely convinced by the claims.

I think this is very exciting work, says Pennsylvania State Universitys Gong Chen of the Nature paper. It reaffirms that using the brains internal glial cells to regenerate new neurons is a really new avenue for the treatment of brain disorders, he continues. Chen, who is also based at Jinan University and is the chief scientific officer for NeuExcella company developing astrocyte-to-neuron conversion therapieshas performed such conversions in the living mouse brain by a different method but was not involved in the new study.

In Parkinsons disease, dopaminergic neurons within the brains substantia nigraa region in the midbrain involved in movement and rewardgradually die. This results in a deterioration of motor control, characterized by tremors and other types of dyskinesia, with other faculties such as cognition and mood sometimes affected too, especially at later stages of the disease. While treatments to boost diminishing dopamine levels, such as the drug levodopa, can ameliorate symptoms, none can stop the underlying disease process that relentlessly eats away at the patients neurological functions and quality of life.

In the search for disease-modifying therapies, researchers are investigating ways to regenerate or replace the missing neurons. One strategy is to inject stem cellderived neurons into the brain. While this approach, using donor stem cells, is already in a clinical trial, it is far from ideal. The use of donor cells runs the risk of potential immune rejection. On the other hand, using a patients own cells would be costly and time-consuming.

Another approach gaining momentum is to directly transform non-neuronal cells in the midbrain into neurons, which in principle should be simpler and faster than injecting lab-grown neurons. Chen and colleagues have shown that boosting the production of two transcription factors that induce neurogenesisNeurod1 and Dlx2in the brains of mice can convert astrocytes into GABAergic neurons, while others have shown a cocktail of three neurogenic transcription factors can convert astrocytes into dopaminergic neurons in mouse brains.

Instead of adding transcription factors, Xiang-Dong Fu of the University of California, San Diego, and colleagues new approach relies on removing an inhibitor of neurogenesis. Work from his lab had shown that the RNA binding protein PTB prevents the activation of neuronal factors in non-neuronal cells and that deleting it could convert fibroblasts into neurons in culture. Its like a key, he says. You . . . turn the machine on and then you dont need it anymore. Now, Fus group shows in Nature that the approach works directly in the living brain.

Using genetically engineered mice in which astrocyte-specific production of PTB could be switched off at will by injecting a silencing RNA, the team observed that several weeks after PTB depletion, the cells began producing neuronal markers, with the number of ex-astrocytes producing such markers increasing as the weeks went by. Interestingly, injections at different sites in the brain induced different types of neuronswith injections to the substantia nigra producing the highest abundance of dopaminergic neurons. This suggested that while PTB inhibition enabled neuronal conversion, unknown factors within the astrocytes themselves, or their surrounding environment, influenced the neuronal subtype they became. The team went on to show that the converted cells could innervate other brain regions and could form functional synapses.

The team then tested its method in mice whose substantiae nigrae were injected with 6-hydroxydopaminea dopamine analog toxic to dopaminergic neuronsto mimic Parksinons disease. They showed that astrocyte-specific PTB depletion in these mice boosted the numbers of dopamine neurons and the production of dopamine itself, and improved the animals motor functions within three months of the treatment. Animals that did not receive PTB-depletion treatment showed poorer limb use and increased rotational movementsboth standard measures of motor function impairments caused by dopaminergic neuron losscompared with treated animals. The recent paper in Cell by an independent group has shown similar results.

The results . . . present intriguing possibilities for cell replacement strategies, Marina Emborg, a Parkinsons disease researcher at the University of Wisconsin-Madison who was not involved in the studies, writes in an email to The Scientist. The safe clinical translation of this method will need to consider whether the number of astrocytes present in the [patient] brain is enough for effective cell replacement and whether shifting astrocytes into neurons affects brain homeostasis. Also, the researchers will need to assess whether the changed cells remain with a neuronal phenotype and for how long they survive, she adds.

The papers reports of cell transformation dont convince Ole Isacson of Harvard Medical School who works on stem cellderived neurons for treating Parkinsons disease. Turning astrocytes into neurons is something a lot of scientists would want to do, he says, but it is possible what the scientists are calling astrocyte-derived neurons are actually preexisting neurons. The astrocyte-specific machinery of the teams transgenic mice might to some extent leak into surrounding neurons, he says, giving such neurons the appearance of having once been astrocytes. He also says he thinks the teams should test their approaches in a range of robust Parkinsons disease models.

While Fu is convinced his cells are the real deal, there is one problem he admits the approach faces: that it didnt work as effectively in older animals as in younger ones. Experiments in young mice are all very well, but Parkinsons disease affects the elderly, says Chen, so showing the cells can still be converted at older ages, is a critical thing.

H. Qian et al., Reversing a model of Parkinsons disease with in situ converted nigral neurons,Nature, doi:10.1038/s41586-020-2388-4, 2020.

H. Zhou et al., Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice,Cell, doi:10.1016/j.cell.2020.03.024, 2020.

Read more from the original source:
Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice - The Scientist

Survey: Impact Of Covid-19 On Media for Stem Cell Market 2020 Industry Outlook, Opportunities in Market and Expansion By 2026 – Cole of Duty

The thorough information about the Media for Stem Cell Market Report comprises the global data, figures, and essential statistics. However, this report also has information about the year 2020 until the forecasting for the year 2026. Moreover, the effects of the pandemic COVID-19 on the industry are also incorporated in this report on the industry as per the local and international markets. This report has been exclusively studied and analyzed by the experts of various domains to meet the success of the reports in the industry.

Get Sample PDF Copy (including COVID19 Impact Analysis, full TOC, Tables, and Figures) of Media for Stem Cell Market Report @ https://www.esherpamarketreports.com/request-sample/es-427598/

The Media for Stem Cell Market Report has answers to all your questions such as:

Key Businesses Segmentation of Media for Stem Cell Market:

By Types, the Media for Stem Cell Market can be Splits into:

By Applications, the Media for Stem Cell Market can be Splits into:

List of Top Key Players of Media for Stem Cell Market:

Thermo Fisher,STEMCELL Technologies,Merck Millipore,Lonza,GE Healthcare,Miltenyi Biotec,PromoCell,Corning,CellGenix,Takara,HiMedia

Enquire before purchasing this report @ https://www.esherpamarketreports.com/pre-order-enquiry/es-427598

Reasons To Buy Media for Stem Cell Market Report :

Purchase this Report with Full Access @ https://www.esherpamarketreports.com/purchase/es-427598/

Media for Stem Cell Market TOC Covers the Following Points:

Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Major Country Wise Market Analysis Chapter 2 Major Segmentation (Classification, Application and etc.) Analysis 2.1 Brief Introduction by Major Application 2.2 Brief Introduction by Major Type Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2015-2020 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2015-2020 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2015-2020 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 Asia-Pacific Market 3.2.4 Europe Market 3.2.5 Central & South America Market 3.2.6 Middle East & Africa Market 3.2.7 Other Regions Market Chapter 4 Sales Market Analysis 4.1 Global Sales Market Analysis 4.1.1 2015-2020 Global Sales Volume, Sales Price and Sales Revenue Analysis 4.1.2 2015-2020 Major Manufacturers Performance and Market Share 4.2 Regional Sales Market Analysis 4.2.1 2015-2020 Regional Market Performance and Market Share 4.2.2 North America Market 4.2.3 Asia-Pacific Market 4.2.4 Europe Market 4.2.5 Central & South America Market 4.2.6 Middle East & Africa Market 4.2.7 Other Regions Market Chapter 5 Consumption Market Analysis 5.1 Global Consumption Market Analysis

Click Here For Detailed Table Of Contents

Contact Us:

Name: Jason George

Email: [emailprotected]

Call :USA: +1 408 757 0510

Organization: eSherpa Market Reports

About Us:

eSherpa Market Reports is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segment.

Go here to see the original:
Survey: Impact Of Covid-19 On Media for Stem Cell Market 2020 Industry Outlook, Opportunities in Market and Expansion By 2026 - Cole of Duty

BIOBANKS MARKET COMPETITIVE LANDSCAPE ANALYSIS WITH FORECAST BY 2025 – 3rd Watch News

Global Biobanks Market: Overview

The global biobanks market owes its conception to the rising need for replacement organs and the steady advancement in the replacement and transfusion technologies regarding a number of bodily substances. Though the technology and need to store organs and other bio-entities had been available for a long time, the global biobanks market took on a more important role in the healthcare sector following the increasing research in genomics. In the new millennium, the development of the personalized medicine field has been the vital driver for the global biobanks market. The likely advancement of the latter, thanks to helpful government regulations, is likely to make the crucial difference for the global biobanks market in the near future.

The steady technological advancement in the healthcare sector in the last few decades has now led to a scenario where the full potential of biobanks can be harnessed. As a result, the global biobanks market is projected to exhibit steady growth over the coming years.

Global Biobanks Market: Key Trends

The rising interest in personalized medicine is the prime driver for the global biobanks market. Personalized medicine has only become a viable branch of modern medicine after steady research in genomics and the way various patients react to various medicines. The biobanks market has thus come into the spotlight thanks to their role as a steady supplier of human biomaterials for research as well as direct application. The increasing research in genomics following the findings of the Human Genome Project is thus likely to remain a key driver for the global biobanks market in the coming years.

The utilization of biobanks in stem cell research has been hampered in several regions by ethical concerns regarding the origin of stem cells. Nevertheless, the potential of stem cells in the healthcare sector is immense, and is likely to have a decisive impact on the trajectory of the global biobanks market in the coming years. Many countries have, in recent years, adopted a supportive stance towards stem cell research, aiding the growth of the biobanks market. Continued government support is thus likely to remain vital for the global biobanks market in the coming years.

Global Biobanks Market: Market Potential

The leading role of the U.S. in the global biobanks market is unlikely to change in the coming years. The easy availability of government-supported healthcare infrastructure and the presence of several industry giants in the region has driven the biobanks market in the U.S.

Northwell Health, the largest healthcare provider in New York State, earlier in 2017 initiated a new biobank aimed at creating precision therapies against various types of cancer. Launched in collaboration with Indivumed, the biobank will provide catalogued biomaterials for research into lung, colorectal, breast, and pancreatic cancer. This would enable targeted, gene-specific studies of a variety of cancer samples, leading to a more comprehensive understanding of cancer. Such well-funded collaboration efforts are crucial for the developing biobanks market.

Global Biobanks Market: Geographical Dynamics

Led by the fertile healthcare research scenario in the U.S., North America is likely to retain a dominant share in the global biobanks market in the coming years. Steady support from institutes such as the NIH is likely to be vital for the North America biobanks market.

Emerging Asia Pacific economies such as India and China could emerge with a significant share in the global biobanks market in the coming years. The healthcare sector in both countries has received steady public or private funding in the last few years. India is also a global leader in medical tourism and is likely to receive an increasing number of patients in the coming years, leading to promising prospects for the global biobanks market in the region.

Global Biobanks Market: Competitive Dynamics

Due to the dynamic nature of the global biobanks market, with advancements in diagnostic fields often determining the direction of the market, the market is heavily fragmented. It is likely to retain a significant degree of fragmentation in the coming years thanks to the diversity in the application segments of the biobanks market. The leading players in the global biobanks market includeBioCision, Tecan Group, VWR, Beckman Coulter Inc., and Thermo Fisher Scientific.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

More:
BIOBANKS MARKET COMPETITIVE LANDSCAPE ANALYSIS WITH FORECAST BY 2025 - 3rd Watch News

Hematopoietic Stem Cell Transplantation (HSCT) Market Expand Their Businesses With New Investments In 2020 And Coming Future – Bulletin Line

Hematopoietic Stem Cell Transplantation (HSCT) Market report provides (6 Year Forecast 2020-2026) including detailed Coronavirus (COVID-19) impact analysis on Market Size, Regional and Country-Level Market Size, Segmentation Market Growth, Market Share, Competitive Landscape, Sales Analysis and Value Chain Optimization. This Hematopoietic Stem Cell Transplantation (HSCT) market competitive landscape offers details by topmost key manufactures (Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc, Escape Therapeutics Inc, Cryo-Save AG, Lonza Group Ltd, Pluristem Therapeutics Inc, ViaCord Inc) including Company Overview, Company Total Revenue (Financials), Market Potential, Presence, Hematopoietic Stem Cell Transplantation (HSCT) industry Sales and Revenue Generated, Market Share, Price, Production Sites and Facilities, SWOT Analysis, Product Launch. For the period 2014-2020, this study provides the Hematopoietic Stem Cell Transplantation (HSCT) sales, revenue and market share for each player covered in this report.

Key Target Audience of Hematopoietic Stem Cell Transplantation (HSCT) Market: Manufacturers of Hematopoietic Stem Cell Transplantation (HSCT), Raw material suppliers, Market research and consulting firms, Government bodies such as regulating authorities and policy makers, Organizations, forums and alliances related to Hematopoietic Stem Cell Transplantation (HSCT) market.

Get Free Sample PDF (including COVID-19 Impact Analysis, full TOC, Tables and Figures)of Hematopoietic Stem Cell Transplantation (HSCT)[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2276986

Synopsis of Hematopoietic Stem Cell Transplantation (HSCT) Market:In 2019, the market size of Hematopoietic Stem Cell Transplantation (HSCT) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hematopoietic Stem Cell Transplantation (HSCT).

Based onProduct Type, Hematopoietic Stem Cell Transplantation (HSCT) market report displays the manufacture, profits, value, and market segment and growth rate of each type, covers:

Allogeneic Autologous

Based onend users/applications, Hematopoietic Stem Cell Transplantation (HSCT) market report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, this can be divided into:

Peripheral Blood Stem Cells Transplant (PBSCT) Bone Marrow Transplant (BMT) Cord Blood Transplant (CBT)

Hematopoietic Stem Cell Transplantation (HSCT) Market: Regional analysis includes:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2276986

The Hematopoietic Stem Cell Transplantation (HSCT) Market Report Can Answer The Following Questions:

What are the Upstream Raw Materials And Manufacturing Equipment of Hematopoietic Stem Cell Transplantation (HSCT)? What is the manufacturing process of Hematopoietic Stem Cell Transplantation (HSCT)?

Who are the key manufacturers of Hematopoietic Stem Cell Transplantation (HSCT) market? How are their operating situation (Capacity, Production, Price, Cost, Gross and Revenue)?

Economic impact on Hematopoietic Stem Cell Transplantation (HSCT) industry and development trend of Hematopoietic Stem Cell Transplantation (HSCT) industry.

What is the (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) Production, Production Value, Consumption, Consumption Value, Import And Export of Hematopoietic Stem Cell Transplantation (HSCT)?

What will the Hematopoietic Stem Cell Transplantation (HSCT) Market Size and The Growth Rate be in 2026?

What are the key market trends impacting the growth of the Hematopoietic Stem Cell Transplantation (HSCT) market?

What are the Hematopoietic Stem Cell Transplantation (HSCT) Market Challenges to market growth?

What are the types and applications of Hematopoietic Stem Cell Transplantation (HSCT)? What is the market share of each type and application?

What are the key factors driving the Hematopoietic Stem Cell Transplantation (HSCT) market?

What are the Hematopoietic Stem Cell Transplantation (HSCT) market opportunities and threats faced by the vendors in the Hematopoietic Stem Cell Transplantation (HSCT) market?

Contact:

ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Here is the original post:
Hematopoietic Stem Cell Transplantation (HSCT) Market Expand Their Businesses With New Investments In 2020 And Coming Future - Bulletin Line

Stem Cell Banking Market Report (2020-2025) | The Demand For The Market Will Drastically Increase In The Future – 3rd Watch News

The global Stem Cell Banking market was valued at USD 1.52 billion in 2016 and is projected to reach USD 7.94 billion by 2025, growing at a CAGR of 20.17% from 2017 to 2025.

View Source Of Related Reports:

Viral Inactivation Market Virus Filtration Market Viral Clearance Market Veterinary-Animal Vaccines Market Vaccine Adjuvants Market Terahertz and Infrared Spectroscopy Market Tangential Flow Filtration Market Sterile Filtration Market Stem Cell Banking Market

Stem Cell banking involves preservation of new born placental stem cells or amniotic stem cells as well as adult bone marrow stem cells. The concept ensures health safety in case of a major surgery or organ regeneration needs for the patient. With increasing awareness regarding the practice, the market is expected to boost in near future.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10008449

Sample Infographics:

Market Dynamics: 1. Market Drivers 1.1 Easy Extraction Methods 1.2 High birth ratio 1.3 Increase in GDP and Disposable income in developing nations 1.4 Increasing support from public and private sector 1.5 Scope of stem cell usage in therapeutics and treatment 2. Market Restraints 2.1 Large number of players in the market 2.2 High Cost of technology 2.3 Lack of awareness 2.4 Regulatory restrains

Market Segmentation: 1. By Application: 1.1 Cerebral Palsy 1.2 Thalassemia 1.3 Leukemia 1.4 Diabetes 1.5 Autism 1.6 Others

2. By Services: 2.1 Collection & Transportation 2.2 Processing 2.3 Analysis 2.4 Storage

3. By Bank Type: 3.1 Cord Blood 3.2 Cord Tissue

4. By Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa

Competitive Landscape: The major players in the market are as follows: 1.CBR Systems, Inc. 2. Cordlife 3. Cryo-Cell 4. Cryo-Save AG (A Group of Esperite) 5. Lifecell 6. Stemcyte 7. Viacord 8. Smart Cells International Ltd. 9. Cryoviva India 10. Cordvida 11. China Cord Blood Corporation These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Request For Full Report:https://www.kennethresearch.com/sample-request-10008449

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:Research study on the Stem Cell Bankingmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email:[emailprotected]

Phone: +1 313 462 0609

Read the original:
Stem Cell Banking Market Report (2020-2025) | The Demand For The Market Will Drastically Increase In The Future - 3rd Watch News